Healthcare DIVE October 11, 2018
Samantha Liss

CVS Health’s nearly $70 billion acquisition of Aetna, which got a nod from antitrust regulators Wednesday, is expected to push the industry toward becoming more consumer focused, potentially ease access to care and pair pharmacy data with medical benefit data — all in the hopes of achieving better outcomes and lower costs.

With a deal that’s nearly unprecedented in scale for the industry, experts weighed in on the key takeaways and how executives around the sector should view the changing landscape.

Threat to providers

Insurers are seeking better engagement with members to allow them to intervene when health conditions arise. By teaming up with CVS, Aetna is in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Healthcare System, Insurance, Mergers & Acquisitions / JV, Payer, Pharma, Physician, Primary care, Provider, Retail care, Trends
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Concerns raised over Indiana hospital merger
Medtronic buys surgical instrument developer Fortimedix

Share This Article